Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
Overall SRT3 gets a fundamental rating of 3 out of 10. We evaluated SRT3 against 20 industry peers in the Life Sciences Tools & Services industry. SRT3 has a bad profitability rating. Also its financial health evaluation is rather negative. SRT3 is valied quite expensively at the moment, while it does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.56 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.75 | ||
| Fwd PE | 42.82 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.49 | ||
| EV/EBITDA | 25.32 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 56.75 and the Price/Book (PB) ratio is 7.26.
The financial health rating of SARTORIUS AG-VORZUG (SRT3.DE) is 1 / 10.